Key Highlights

  • Revenue at The Pennant Group (NASDAQ:PNTG) rose to USD 302.3 million from USD 229.0 million, roughly 32% (calculated), while profit attributable to shareholders reached USD 9.6 million, which is USD 0.26 per diluted share.
  • Option Care Health (NASDAQ:OPCH) posted a 4.1% jump in net revenue, reaching USD 1,493.5 million, and a 10.8% gain in Net Income to USD 57.4 million, with a USD 32.05 per-share cash deal pending.
  • Acadia Healthcare (NASDAQ:ACHC) generated USD 895.3 million of revenue, up 5.1%, but diluted profit per share dropped to USD 0.38 from USD 0.40 as income tax expense increased to USD 17.8 million.
  • Ardent Health (NYSE:ARDT) moved back into profit with USD 45 million of net income, or USD 0.31 per diluted share, and its 2026 Adjusted EBITDA guidance floor now stands at USD 500 million.

The Pennant Group (NASDAQ:PNTG): Revenue Growth Rides on Purchased Home Health Business

The Pennant Group (NASDAQ:PNTG) reported on November 4, 2026 for the period closing September 30, 2026. Sales came to USD 302.3 million against USD 229.0 million, which amounts to about 32% growth (calculated). Home health and hospice contributed USD 239.8 million, versus USD 173.5 million the year before, and home health admissions totaled 28,479, up from 20,426. The increase follows the transfer of operations acquired from UnitedHealth, Amedisys and additional sellers, effective October 1, 2025. Operating Margin reached 5.5% of revenue, up from 4.4%, because general and administrative costs declined to 6.8% of revenue from 8.4%. Attributable net income expanded roughly 58% (calculated), but net interest expense, moving from USD 1.0 million to USD 3.6 million, more than tripled. Borrowings stood at USD 199.3 million, compared with USD 175.0 million at the prior year-end. Average Medicare revenue for each completed home health episode fell to USD 3,632 from USD 3,712. The filing names reimbursement changes under Medicare and Medicaid, staffing requirements and assimilating the acquired operations as principal risks. No Earnings forecast appears in the sections reviewed, so forward figures are not quantified here.

Option Care Health (NASDAQ:OPCH): Steady Operating Quarter Before a Fixed USD 32.05 Cash Sale

Option Care Health (NASDAQ:OPCH) delivers infusion services in homes and at alternate sites, and it submitted its quarterly filing on November 4, 2026. Net revenue went up 4.1% to USD 1,493.5 million, led by acute therapies, while Operating Income reached USD 89.2 million compared with USD 84.5 million. Net income climbed 10.8% to USD 57.4 million, equal to USD 0.38 per diluted share. An October 5, 2026 Merger accord would hand control to an investor group made up of affiliates of Clayton, Dubilier & Rice and McKesson, paying USD 32.05 in cash for each share. The closing window runs into the first half of calendar 2027 and depends on a majority stockholder vote, the end of the Hart-Scott-Rodino Waiting Period and clearance from health regulators. Under certain conditions the company would have to pay a termination fee of approximately USD 145.96 million. This year the company repurchased 7.9 million shares for USD 167.5 million, an average of USD 21.26 apiece, which places the offer roughly 51% above that level (calculated). Because the price is locked in, any future Business gains would not flow to shareholders. A legal challenge to the transaction is among the risks listed.

Acadia Healthcare (NASDAQ:ACHC): Higher Pretax Income Undone by a 31.6% Effective Tax Rate

Acadia Healthcare (NASDAQ:ACHC) released its quarterly numbers on November 4, 2026. The behavioral health provider operated 280 locations with around 12,800 beds at the close of the quarter. Sales rose 5.1% to USD 895.3 million, same-facility admissions increased 6.6%, and revenue per patient day moved up 4.0%. Pretax income went from USD 40.0 million to USD 56.5 million, a rise of about USD 16.5 million (calculated). Tax expense, however, jumped to USD 17.8 million from USD 1.7 million, since the year-earlier quarter had recorded a tax benefit, and the filing identifies nondeductible legal settlements and valuation allowances as drivers. The effective rate hit 31.6%, versus 4.2% in the prior-year period. Net income attributable to the company eased to USD 34.5 million from USD 36.2 million, leaving diluted EPS at USD 0.38 instead of USD 0.40. Transaction, legal and related expenses were cut to USD 23.7 million from USD 42.9 million. Cash stood at USD 163.3 million, and USD 710.1 million remained available on the revolver. Covenant-based Leverage registered 3.9 times, within the ceilings, while Days Sales Outstanding stretched to 52 days from 49. The filing flags tighter Medicaid rules under the One Big Beautiful Bill Act as a risk. No guidance or consensus comparison is included.

Ardent Health (NYSE:ARDT): Profit Return and Higher EBITDA Floor Despite Flat Admissions

Brentwood, Tennessee-based Ardent Health (NYSE:ARDT) published its third-quarter 2026 report on November 4, 2026. It runs 30 acute care hospitals spread across six states. Net income attributable to the company came to USD 45 million, or USD 0.31 per diluted share, after posting a loss of USD 23 million, or USD 0.17, a year before. Revenue improved 3.1% to USD 1,625 million, adjusted admissions rose 2.9%, and yet total admissions barely changed while total surgeries slipped 1.9%. Management attributed the turnaround to its IMPACT program, which is tracking toward at least USD 70 million in savings this year, along with a 4% drop in salaries, wages and benefits. The 2026 Adjusted EBITDA range is now USD 500 million to USD 535 million, with the low end raised from USD 485 million, while the USD 6,400 million to USD 6,700 million revenue range stays put. Cash reached USD 766 million, against USD 1.1 billion of total Debt and net leverage of 0.8 times. The board expanded the buyback by USD 25 million, and capex guidance sits at USD 210 million to USD 250 million. The improvement stemmed mostly from cost discipline rather than patient volume, and a call is scheduled for November 5, 2026.

Where Things Stand

Growth alone does not account for the strongest result in this group. The Pennant Group (NASDAQ:PNTG) posted a roughly 32% revenue gain (calculated) alongside a sharp rise in interest expense. Option Care Health (NASDAQ:OPCH) delivered steady numbers that now sit below a fixed USD 32.05 cash offer. Acadia Healthcare (NASDAQ:ACHC) illustrates how taxes can wipe out operating progress. Ardent Health (NYSE:ARDT) recovered largely through cost reductions, with admissions flat. Watch for the Option Care Shareholder vote, the Acadia tax line, Ardent surgical volumes and how Pennant integrates its purchases.